Search Results - "Cotter, Dennis"

Predicting Early Death Among Elderly Dialysis Patients: Development and Validation of a Risk Score to Assist Shared Decision Making for Dialysis Initiation by Thamer, Mae, PhD, Kaufman, James S., MD, Zhang, Yi, PhD, Zhang, Qian, MPH, Cotter, Dennis J., MSE, Bang, Heejung, PhD

“…Background A shared decision-making tool could help elderly patients with advanced chronic kidney disease decide about initiating dialysis therapy. Because…”
Get full text

125-OR: Association between Preventive Podiatric Care and Outcomes of New Diabetic Foot Ulceration among Patients with End Stage Renal Disease by TAN, TZE-WOEI, ARMSTRONG, DAVID G., CHONG, CHYI CHYI, HAMILTON-COTTER, NICHOLAS J., KSHIRSAGAR, ONKAR S., MARRERO, DAVID G., COTTER, DENNIS J.

“…Objective: To assess the association between foot care by podiatric surgeons and outcomes of new diabetic foot ulceration (DFU) among patients with end-stage…”
Get full text

Prednisone, Lupus Activity, and Permanent Organ Damage by THAMER, Mae, HERNAN, Miguel A, YI ZHANG, COTTER, Dennis, PETRI, Michelle

“…Objective. To estimate the effect of corticosteroids (prednisone dose) on permanent organ damage among persons with systemic lupus erythematosus (SLE)…”
Get full text

The Effect of Dialysis Chains on Mortality among Patients Receiving Hemodialysis by Zhang, Yi, Cotter, Dennis J., Thamer, Mae

“…Objective. To examine the association between dialysis facility chain affiliation and patient mortality. Study Setting. Medicare dialysis population. Study…”
Get full text

Erythropoiesis-Stimulating Agent Use Among Non–Dialysis-Dependent CKD Patients Before and After the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Using a Large US Health Plan Database by Thamer, Mae, PhD, Zhang, Yi, PhD, Kshirsagar, Onkar, MSE, Cotter, Dennis J., MSE, Kaufman, James S., MD

“…Background In a landmark study, TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) examined the use of erythropoiesis-stimulating agent (ESA)…”
Get full text

Dialysis Chains and Placement on the Waiting List for a Cadaveric Kidney Transplant by Zhang, Yi, Thamer, Mae, Kshirsagar, Onkar, Cotter, Dennis J, Schlesinger, Mark J

“…BACKGROUNDThe proliferation of multi-unit for-profit dialysis chains in the ESRD industry has raised concerns for patient quality of care including access to…”
Get full text

Foot and Ankle Care by Podiatrists and Amputations in Patients With Diabetes and Kidney Failure by Tan, Tze-Woei, Caldwell, Bryan, Zhang, Yi, Kshirsagar, Onkar, Cotter, Dennis J, Brewer, Thomas W

“…Patients with kidney failure have an increased risk of diabetes-related foot complications. The benefit of regular foot and ankle care in this at-risk…”
Get full text

Reevaluating erythropoiesis-stimulating agents by Cotter, Dennis J

Get full text

High doses of epoetin do not lower mortality and cardiovascular risk among elderly hemodialysis patients with diabetes by Zhang, Yi, Thamer, Mae, Kaufman, James S., Cotter, Dennis J., Hernán, Miguel A.

“…A randomized trial had suggested that high doses of erythropoiesis-stimulating agents (ESAs) might increase the risk of cardiovascular outcomes in predialysis…”
Get full text

Estimated Effect of Epoetin Dosage on Survival among Elderly Hemodialysis Patients in the United States by Zhang, Yi, Thamer, Mae, Cotter, Dennis, Kaufman, James, Hernán, Miguel A

“…The common finding that low achieved hemoglobin in observational studies and high target hemoglobin in randomized trials each were associated with increased…”
Get full text

Organizational Status of Dialysis Facilities and Patient Outcome: Does Higher Injectable Medication Use Mediate Increased Mortality? by Zhang, Yi, Thamer, Mae, Kshirsagar, Onkar, Cotter, Dennis J.

“…Objective Examine the mediating effect of injectable drugs in the relationship between dialysis facility organizational status and patient mortality. Study…”
Get full text

Hematocrit was not validated as a surrogate end point for survival among epoetin-treated hemodialysis patients by Cotter, Dennis J., Stefanik, Kevin, Zhang, Yi, Thamer, Mae, Scharfstein, Daniel, Kaufman, James

“…To evaluate the use of hematocrit as a surrogate end point for survival among end-stage renal disease (ESRD) patients treated with epoetin. Using United States…”
Get full text

Factors Influencing Route of Administration for Epoetin Treatment Among Hemodialysis Patients in the United States by Thamer, Mae, Zhang, Yi, Kaufman, James, Stefanik, Kevin, Cotter, Dennis J.

“…Background: Published clinical guidelines advocate subcutaneous (SC) administration for epoetin therapy, although this is practiced among only 7% of all…”
Get full text

Relative Mortality and Epoetin Alfa Dose in Hemodialysis Patients by Cotter, Dennis J., MSE, Thamer, Mae, PhD, Zhang, Yi, DDS, MS

Get full text

IS THE EVIDENCE FOR HIGH HEMATOCRIT TARGETS VALID? by Cotter, Dennis J.

Get full text

Dialysis Facility Ownership and Epoetin Dosing in Patients Receiving Hemodialysis: The Authors Respond by Thamer, Mae, PhD, Zhang, Yi, MS, Kaufman, James, MD, Cotter, Dennis, MSE, Hernán, Miguel A., MD

Get full text

Epoetin requirements predict mortality in hemodialysis patients by YI ZHANG, THAMER, Mae, STEFANIK, Kevin, KAUFMAN, James, COTTER, Dennis J

“…Anemia is a frequent complication of end-stage renal disease. Poor responsiveness to epoetin therapy hampers the management of anemia. Escalating epoetin doses…”
Get full text

Improved Survival with Higher Hematocrits: Where is the Evidence? by Cotter, Dennis J., Stefanik, Kevin, Zhang, Yi, Thamer, Mae

“…ABSTRACT The Centers for Medicare and Medicaid Services (CMS) is reviewing Medicare coverage policy for recombinant human erythropoietin (epoetin) therapy. CMS…”
Get full text

Does dose matter? by Zhang, Yi, Thamer, Mae, Stefanik, Kevin, Cotter, Dennis J.

Get full text

Epoetin requirements predict mortality in hemodialysis patients by Zhang, Yi, Thamer, Mae, Stefanik, Kevin, Kaufman, James, Cotter, Dennis J.

“…Background: Anemia is a frequent complication of end-stage renal disease. Poor responsiveness to epoetin therapy hampers the management of anemia. Escalating…”
Get full text